TTAN heads into its June 3 earnings date having clawed back 8.6% on the week to $62.45, yet the short thesis has barely budged — and the Street's target cuts have yet to catch up with the recovery.
Short positioning is real and elevated. SI % FF runs at 9.7% of free float, a level that has barely moved since late April when it jumped from the high 8s after shorts added roughly one percentage point in a single step. The share count short has drifted fractionally lower this week — down less than 0.2% — but the broader picture is one of persistence: shorts built into early May and have shown no appetite to cover into the week's rally. Borrow costs are cheap, at 0.42% APR, a level that gives no economic incentive to rush a cover. Availability is ample at 620%, meaning there is no pressure on the lending side that would force a squeeze. The setup is crowded relative to the stock's own history, but not stressed.
Options traders are notably calm about all of this. The put/call ratio is running at 0.48, essentially in line with its 20-day average of 0.49 and a z-score of just -0.24 — squarely in neutral territory. The contrast with the first half of April is worth noting: PCR spent much of that period closer to 0.52-0.54, reflecting more defensive hedging. The current read suggests options market participants are neither pressing protection nor loading up on calls ahead of the June 3 print, an unusually composed posture given recent earnings history.
That history argues for some caution. Both available earnings events in the dataset show the stock fell on the day of results — down 9.8% and 6.3% respectively — with further losses in the subsequent five days (-12.7% and -10.5%). The pattern is consistent: TTAN has rewarded bears at reporting time, which makes the low PCR all the more notable. Either the options market is dismissing recent precedent, or participants believe the setup has materially changed ahead of this quarter.
The Street has done significant target-cutting but remains broadly positive on direction. BTIG lowered its target from $105 to $90 on Tuesday while keeping a Buy. Piper Sandler trimmed to $100 in April. Goldman Sachs, Citigroup, and a cluster of other firms all cut following the March print, with reductions ranging from $10 to $35. The consensus mean target is $101, representing roughly 62% upside from current levels — a gap that reflects either genuine conviction or targets that haven't caught down to reality fast enough after a stock off more than 40% year-to-date. Bulls point to a $31 billion TAM, the company's grip on the trades vertical, and recently added AI tooling through its Max platform. Bears note FY27 growth guidance of just 16% — modest for a stock priced at nearly 10x EV/revenue — and the risk that adoption in SMB trades businesses remains slow. The EV/EBITDA multiple is 26.5x, down roughly 0.6x over the past 30 days, suggesting some valuation compression even as the stock recovered this week.
Institutional ownership has a couple of noteworthy moves. Co-founders Ara Mahdessian and Vahe Kuzoyan — who together hold nearly 15% of shares — both trimmed materially in the latest quarter, selling 2.3 million and 3.3 million shares respectively. Kayne Anderson Rudnick added 1.4 million shares, Millennium built a position of 1.76 million shares, and Citadel added 1.3 million. The picture is mixed: growth-oriented managers buying while insiders reduce. Insider sells in March were small-lot transactions at $69.86 — near the highs — and carry low significance scores; they look more like programmatic dilution than directional calls.
HUBS jumped 15.9% on the week, ASAN added 10.3%, and FRSH gained 7.3% — a sector bid that lifted most of TTAN's closest peers and provides the context for the stock's own 8.6% move. The short score has been declining steadily through the week, from 58.9 on May 12 to 54.7 on May 19, tracking the price recovery. What to watch on June 3 is whether revenue growth and usage metrics support the multiple at current levels, or whether the recurring post-earnings drawdown pattern repeats.
See the live data behind this article on ORTEX.
Open TTAN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
